Europe Syringes Market Research Report - Segmented By Usability, Material, Type & Country(UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2024 to 2029)

Updated On: January, 2024
ID: 1848
Pages: 145

Europe Syringes Market Size (2023 to 2028)      

The size of the European syringes market is expected to grow at a CAGR of 8% from 2023 to 2028. As a result, this market is forecasted to grow to USD 4.93 billion in 2028 from USD 3.35 billion in 2023.

The increased demand for syringes and technological developments in the manufacturing of syringes are majorly propelling the growth of the European syringes market. Growing investments from the EU governments to enhance the healthcare ecosystem; the growing incidence of chronic and pandemic diseases such as diabetes, infectious diseases, and cardiovascular diseases across Europe is demanding more production of syringes, which is boosting the market growth. In addition, the increasing patient population needs more and more syringes for treatment procedures, further promoting product demand. Furthermore, private and government investments in research and development facilities are anticipated to create growth opportunities. 

Furthermore, the market is also driven by the increased use of prefilled syringes and injectable medications and growing demand for Botox therapeutics purposes. Due to the increased use of advanced technology and numerous products that benefit end consumers, the European syringes market is expected to grow. In addition, YOY's growth in surgical procedures, vaccination, and immunization drive against viruses such as COVID-19, typhoid, and others are expected to offer substantial growth possibilities to the market in this region.

On the other hand, the European syringes market is estimated to be hampered by the availability of alternative drug delivery techniques, such as the insulin pen used to inject insulin in diabetic patients. In addition, the market faces substantial obstacles, including a shortage of qualified workers in the manufacturing area and an increase in the number of needlestick injuries.

This research report on the European syringes market has been segmented and sub-segmented into the following categories:

Europe Syringes Market - By Usability:

  • Sterilizable/reusable
    • Hypodermic
    • Oral
  • Disposable Syringes
    • Conventional
    • Safety
    • Prefilled

Europe Syringes Market - By Material:

  • Glass Syringes
  • Plastic Syringes

Europe Syringes Market - By Type:

  • General Syringes
  • Specialized Syringes
    • Insulin
    • Tuberculin
    • Allergy
    • Others

Europe Syringes Market - By Country: 

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Geographically, the European syringes market held a substantial share in the global market in 2020 and is majorly driven by improved technology in medical testing facilities and government programs that provide funding. In addition, most syringes and needles in Europe are sold individually and combined as needed. However, some particular markets, such as Italy, where strong sales of pre-attached syringes and needles make the stand-alone market modest in comparison.

The UK syringes market was the largest regional market in Europe and is expected to remain so throughout the forecast period.

The syringes market in Germany is anticipated to grow considerably during the forecast period. Germany is known for developing and mass-producing innovative new syringes. As a result, Germany is the world's largest syringe exporter, accounting for 8.69 percent of syringes sent to industrialized countries. In the German syringe market, B. Braun, Melungen AG, Schott AG, and Gerresheimer AG have most of the market share.

Regarding healthcare infrastructure and the pharmaceutical industry, Russia is the fastest-growing country. Russia has the most significant market share for insulin syringes. Diabetic patients are becoming more common in the country, fueling market expansion. Insulin syringes and shipments are imported into Russia. However, Russia's low costs and strict restrictions on local syringe exchange hampered the market growth. By focusing on drug injectors, pharmacy-based syringe distribution and exchange will assist in enhancing the cost-effectiveness of HIV prevention.


A few of the prominent companies operating in the European syringes market profiled in this report are Terumo Corporation, B. Braun Medical Inc., Medtronic plc, Becton, Dickinson and Company, Smiths Medical, NIPRO Corporation, Gerresheimer AG, Hindustan Syringes & Medical Devices Limited, SCHOTT AG, and CODAN Medizinische Geräte GmbH & Co KG.

Please wait. . . . Your request is being processed

Frequently Asked Questions

What factors contribute to the growth of the syringes market in Europe?

Factors such as increasing healthcare awareness, rising prevalence of chronic diseases, and advancements in medical technology are driving the growth of the syringes market in Europe.

How are government regulations impacting the Europe syringes market?

Stringent regulations are influencing market dynamics by promoting the adoption of safety measures in syringe design and production.

Are there any challenges hindering the growth of the Europe syringes market?

Challenges include pricing pressures, concerns about needlestick injuries, and the environmental impact of disposable syringes.

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1400

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample